40
Participants
Start Date
July 31, 2009
Primary Completion Date
October 31, 2010
Study Completion Date
August 31, 2015
rituximab
Increased dose (750 mg/m2) intravenously for 4 weekly doses followed by maintenance dosing once every three months for up to 2 years. Maintenance dose is standard (375 mg/m2).
Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston
Collaborators (1)
Dana-Farber Cancer Institute
OTHER
Brigham and Women's Hospital
OTHER
Genentech, Inc.
INDUSTRY
Massachusetts General Hospital
OTHER